It is important to note that while LC3A is typically downregulated in many types of cancer, it did not show significant activation of pro-apoptotic pathways in this study, indicating that the mechanism examined by Monastyrska et al. [46] may not translate directly to humans. The gene discussed is MAP1LC3A; the disease is cancer.